Last Updated: November 8, 2026

ORMALVI Drug Patent Profile

Name: ORMALVI Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Ormalvi, and what generic alternatives are available?

Ormalvi is a drug marketed by Torrent and is included in one NDA.

The generic ingredient in ORMALVI is dichlorphenamide. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ormalvi

A generic version of ORMALVI was approved as dichlorphenamide by RISING on November 18^th, 2025.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ORMALVI?
What are the global sales for ORMALVI?
What is Average Wholesale Price for ORMALVI?

Summary for ORMALVI

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
DailyMed Link:	ORMALVI at DailyMed

Drug patent expirations by year for ORMALVI

Pharmacology for ORMALVI

Drug Class	Carbonic Anhydrase Inhibitor
Mechanism of Action	Carbonic Anhydrase Inhibitors

US Patents and Regulatory Information for ORMALVI

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Torrent	ORMALVI	dichlorphenamide	TABLET;ORAL	215924-001	Dec 29, 2022	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.